Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J Miles

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh, Bin S Teh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomyGuru Sonpavde, Timothy C Thompson, Rajul K Jain, et al.
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh, Bin S Teh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
GLIPR1 tumor suppressor gene expressed by adenoviral vector as neoadjuvant intraprostatic injection for localized intermediate or high-risk prostate cancer preceding radical prostatectomyGuru Sonpavde, Timothy C Thompson, Rajul K Jain, et al.
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.
Pageof 7